Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide
Anaesthesiology Intensive Therapy · 2023
DOI: 10.5114/ait.2023.132910 ↗Kurz gefasst
Leserbrief in der Zeitschrift Anaesthesiology Intensive Therapy, 2023. Verfasst von Guilherme di Camillo Orfali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Malignant Hyperthermia Centre, Department of Anaesthesiology, Pain an Intensive Care, Federal University of São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Neuroleptic Malignant Syndrome, Antiemetics, Rhabdomyolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Dear Editor, Neuroleptic malignant syndrome (NMS) is a rare, idiosyncratic, and po tentially fatal complication of neuro leptic use, with a prevalence of 0.02-2.4% [1].NMS is an important diffe rential dia gnosis of hyperthermia in the periope rative period, with a morta lity rate of 5-20% [2].Early recognition is essential for proper management, impacting morbidity and mortality [2].In this article, we report a postope rative rhabdomyo lysis secondary to NMS, associated with the use of dro peridol and metoclopramide.Addi tionally, we review the most recent diagnostic criteria and treatment pro tocols for NMS.A female patient, 28 years old, 53 kg, 158 cm, was admitted for bilateral mam moplasty with breast implant.She denied previous diseases or addic tions, except for an adverse reaction to intravenous metoclopramide, de scribed as a behavioural change, with agitation and a feeling of imminent death.There were no reports of abnor mal movements or changes in muscle tone at that time.She used oral hor monal contraceptives.The surgery was performed under sedation and a thoracic epidural anaes thesia, lasting 2 hours.She received midazolam 15 mg as a preanaesthetic medication.Induction was performed with fentanyl 100 µg and droperidol 10 mg.A thoracic epidural anaesthe sia was performed at T7-T8 level with 2% lidocaine (100 mg) and 0.5% bupi
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Malignant Hyperthermia Centre, Department of Anaesthesiology, Pain an Intensive Care, Federal University of São Paulo, SP, Brazil.
Zitieren
APA
Orfali, G. D. C., Machado, H. L., Andrade, P. V., Santos, J. M., Silva, M. S., Gomes do Amaral, J. L., & Almeida da Silva, H. C. (2023). Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide. Anaesthesiology Intensive Therapy. https://doi.org/10.5114/ait.2023.132910
Vancouver
Orfali GDC, Machado HL, Andrade PV, Santos JM, Silva MS, Gomes do Amaral JL, et al. Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide. Anaesthesiology Intensive Therapy. 2023. doi:10.5114/ait.2023.132910
BibTeX
@article{Orfali2023,
author = {Orfali, Guilherme di Camillo and Machado, Henrique Louzan and Andrade, Pamela Vieira and Santos, Joilson Moura and Silva, Mary Santos and Gomes do Amaral, José Luiz and Almeida da Silva, Helga Cristina},
title = {Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide},
journal = {Anaesthesiology Intensive Therapy},
year = {2023},
doi = {10.5114/ait.2023.132910}
}
EUVIMED